PANGENX, INC.

Profile

Company Names

PANGENX, INC.

Addresses

2000 COMMONWEALTH AVENUE, SUITE 200, AUBURNDALE, MA 02466

Phone Numbers

617 518 6159

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$1,867,280.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2012-06-29 
$933,640.00 
$10,133,398.00 
$9,199,758.00 
Equity 
1
2011-07-29 
$933,640.00 
$10,133,398.00 
$9,199,758.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LAWRENCE 
 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
SEQUELLA INC   |  TETRAPHASE PHARMACEUTICALS INC   |  DANFORTH PEWTERERS LTD   |  STONEMOR PARTNERS LP   |  STONEMOR OPERATING LLC   |  STONEMOR INDIANA LLC   |  PANGENX, INC.   |  HOLGANIX, LLC   |  CUSTOMINK, LLC   |  SEQUELLA INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  APNIMED, INC.
DAVID 
 
NEAFUS 
EXECUTIVE OFFICER
SUSTAINX INC   |  AFFERENT PHARMACEUTICALS, INC.   |  PANGENX, INC.   |  MICROCHIPS BIOTECH, INC.   |  SYNDEVRX INC   |  ARRAKIS THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  NAYAN THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  KERA THERAPEUTICS, INC.   |  SIGHTSTREAM BIOTHERAPEUTICS, INC.
ERIC 
 
NEUMANN 
DIRECTOR
PANGENX, INC.
DANIEL 
A. 
POSCOVER 
EXECUTIVE OFFICER, DIRECTOR
PANGENX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-07-17
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-29 
2012-07-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#